Sept. 8, 2016 | UAMS biomedical informatics researcher David Ussery, Ph.D., and UAMS cancer treatment researcher Hong-yu Li, Ph.D., were named Arkansas Research Alliance (ARA) Scholars at a news conference today at the State Capitol. Ussery and Li each were presented with a certificate by Gov. Asa Hutchinson ARA Board of Trustees Chair Sonja Hubbard [...]
Researchers from the University of Arkansas for Medical Sciences (UAMS) and other institutions are reporting the discovery of the first broad spectrum drug that can potently kill senescent (or aging) cells in culture and effectively clear the cells in animals by specifically targeting a pathway that is critical for the survival of senescent cells. Findings [...]
UAMS researchers, led by Martin Hauer-Jensen, M.D., have secured a $10.5 million grant to establish a center to study side effects of cancer therapy.
UAMS Researchers Awarded $10.5 Million Grant to Establish Center for Study of Cancer-Therapy Toxicity
LITTLE ROCK – A team of UAMS researchers has secured a $10.5 million grant to establish a center to study side effects of of cancer therapy.
Aug. 27, 2014 | Gareth Morgan, M.D., Ph.D., director of the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy, was named an Arkansas Research Alliance (ARA) Scholar at a news conference today at the State Capitol.